Drugmakers are betting that a new wave of medicines for cancer, diabetes, heart disease, multiple sclerosis and hepatitis will shape up as tomorrow's blockbusters in the coming 12 months.
Drug industry bets on new blockbusters in 2013
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.